Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
CALL
Federal Realty Investment Trust
FRT
$10.2B
| $3.28M | ﹤0.01% |
21,300
+9,700
| +84% | +$1.57M |
|
2752
Packaging Corp of America
PKG
$21.7B
| $3.28M | ﹤0.01% |
40,348
+7,148
| +22% | +$546K |
|
2753
CALL
Televisa
TV
$1.45B
| $3.28M | ﹤0.01% |
127,600
+23,900
| +23% | +$631K |
|
|
NVO
2754
CALL
Novo Nordisk
NVO
$205B
| $3.28M | ﹤0.01% |
+157,600
| New | +$3.91M |
|
2755
CALL
Canadian Imperial Bank of Commerce
CM
$104B
| $3.27M | ﹤0.01% |
84,400
-52,600
| -38% | -$2.03M |
|
|
VIVS
2756
PUT
VivoSim Labs
VIVS
$3.92M
| $3.27M | ﹤0.01% |
3,593
+187
| +5% | +$183K |
|
2757
ProShares Investment Grade-Interest Rate Hedged
IGHG
$343M
| $3.27M | ﹤0.01% |
43,995
+27,914
| +174% | +$2.05M |
|
|
SONC
2758
DELISTED
Sonic Corp
SONC
| $3.26M | ﹤0.01% |
124,655
+29,855
| +31% | +$822K |
|
|
AXDX
2759
DELISTED
Accelerate Diagnostics
AXDX
| $3.26M | ﹤0.01% |
11,965
+8,668
| +263% | +$1.92M |
|
2760
PUT
Dover
DOV
$27.2B
| $3.26M | ﹤0.01% |
54,843
-128,752
| -70% | -$7.45M |
|
2761
PUT
Energizer
ENR
$1.51B
| $3.26M | ﹤0.01% |
65,300
+53,300
| +444% | +$2.62M |
|
2762
PUT
Omega Healthcare
OHI
$14B
| $3.26M | ﹤0.01% |
92,000
+2,900
| +3% | +$103K |
|
|
LUMO
2763
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $3.26M | ﹤0.01% |
24,103
-10,948
| -31% | -$1.09M |
|
|
TSL
2764
CALL
DELISTED
Trina Solar Limited
TSL
| $3.25M | ﹤0.01% |
317,200
-176,200
| -36% | -$1.73M |
|
2765
Brown-Forman Class B
BF.B
$12.5B
| $3.25M | ﹤0.01% |
106,953
-512,231
| -83% | -$15.9M |
|
2766
CALL
AGNC Investment
AGNC
$13B
| $3.24M | ﹤0.01% |
166,000
+43,800
| +36% | +$858K |
|
2767
Kinross Gold
KGC
$38.6B
| $3.24M | ﹤0.01% |
770,533
+104,822
| +16% | +$505K |
|
|
IBKC
2768
CALL
DELISTED
IBERIABANK Corp
IBKC
| $3.24M | ﹤0.01% |
48,300
+11,700
| +32% | +$760K |
|
2769
Dollar General
DG
$27.8B
| $3.24M | ﹤0.01% |
46,306
+17,906
| +63% | +$1.52M |
|
2770
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
| $3.24M | ﹤0.01% |
179,100
-92,400
| -34% | -$1.49M |
|
2771
CALL
Scotiabank
BNS
$113B
| $3.23M | ﹤0.01% |
61,000
-94,700
| -61% | -$4.9M |
|
2772
Hecla Mining
HL
$14.4B
| $3.23M | ﹤0.01% |
566,099
+482,844
| +580% | +$2.95M |
|
2773
PUT
ProShares Ultra Technology
ROM
$1.29B
| $3.23M | ﹤0.01% |
540,800
+94,400
| +21% | +$521K |
|
2774
PUT
Encompass Health
EHC
$11.8B
| $3.23M | ﹤0.01% |
99,932
-22,374
| -18% | -$725K |
|
2775
CALL
Radian Group
RDN
$4.83B
| $3.22M | ﹤0.01% |
237,900
+174,800
| +277% | +$2.25M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.